Patient Guide: A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 50 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05849298
Status: 🟢 Enrolling Now
Condition: Prostatic Neoplasm
Phase: PHASE2

Where You Can Participate

This study is available at 50 locations across the country.

Top locations include:
  • • Mobile, Alabama
  • • Denver, Colorado
  • • Jacksonville, Florida
  • • And 47 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC - Join Clinical Trial NCTNCT05849298

How to Join This Clinical Trial - NCTNCT05849298

Learn how to participate in this PHASE2 trial studying an investigational therapy for Prostatic Neoplasm. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Prostatic Neoplasm. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Prostatic Neoplasm
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05849298 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Mobile, Alabama 36608 - United States

Status: RECRUITING

Clinical Research Site

Denver, Colorado 80218 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32218 - United States

Status: RECRUITING

Clinical Research Site

Athens, Georgia 30607 - United States

Status: RECRUITING

Clinical Research Site

Indianapolis, Indiana 46254 - United States

Status: RECRUITING

Clinical Research Site

Des Moines, Iowa 50323 - United States

Status: RECRUITING

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: RECRUITING

Clinical Research Site

Syracuse, New York 13210 - United States

Status: RECRUITING

Clinical Research Site

Springfield, Oregon 97477 - United States

Status: RECRUITING

Clinical Research Site

York, Pennsylvania 17403 - United States

Status: RECRUITING

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Prostatic Neoplasm:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships